LG
Lachmandas Gelaram Lund
About Lachmandas Gelaram Lund
Data last updated:
Lachmandas Gelaram Lund has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Biotime Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Biotime Pharmaceuticals Private Limited at ₹10.93 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Biotime Pharmaceuticals Private Limited U24110MH2016PTC285926 | Director | 15 Sep 2016 | 2016 | ₹10.93 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Lachmandas Gelaram Lund
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lachmandas Gelaram Lund
Lachmandas Gelaram Lund has 10 years in corporate governance. Holds Director role. Currently with 1 company, including Biotime Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Biotime Pharmaceuticals Private Limited at ₹10.93 Cr (FY 2025).
Lachmandas Gelaram Lund is associated with 1 company as Director, including Biotime Pharmaceuticals Private Limited (₹10.93 Cr).
Lachmandas Gelaram Lund has expertise in General Business.
Lachmandas Gelaram Lund has 10 years in corporate governance.
By reported revenue, the largest current company of Lachmandas Gelaram Lund is Biotime Pharmaceuticals Private Limited, with revenue of ₹10.93 Cr (FY 2025).
Lachmandas Gelaram Lund currently holds positions at 1 company: Biotime Pharmaceuticals Private Limited (₹10.93 Cr).